AN OREXIN 2 RECEPTOR-SELECTIVE AGONIST, TAK-925, SHOWS ROBUST WAKE-PROMOTING EFFECTS IN MICE AND NON-HUMAN PRIMATES

被引：4
|
作者：
Yukitake, H. [1 ]
Ishikawa, T. [1 ]
Suzuki, A. [1 ]
Shimizu, Y. [1 ]
Nakashima, M. [1 ]
Fujimoto, T. [1 ]
Rikimaru, K. [1 ]
Ito, M. [1 ]
Suzuki, M. [1 ]
Kimura, H. [1 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Res, Fujisawa, Kanagawa, Japan
来源：
SLEEP | 2018年 / 41卷
关键词：
D O I：
10.1093/sleep/zsy061.001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
0002
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 20 条
  • [1] TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice
    Yukitake, Hiroshi
    Fujimoto, Tatsuhiko
    Ishikawa, Takashi
    Suzuki, Atsushi
    Shimizu, Yuji
    Rikimaru, Kentaro
    Ito, Mitsuhiro
    Suzuki, Motohisa
    Kimura, Haruhide
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 187
  • [2] Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals
    Evans, Rebecca
    Kimura, Haruhide
    Nakashima, Masato
    Ishikawa, Takashi
    Yukitake, Hiroshi
    Suzuki, Motohisa
    Hazel, James
    Faessel, Helene
    Wu, Jingtao
    Hang, Yaming
    Alexander, Robert
    Rosen, Laura
    Hartman, Deborah S. S.
    Ratti, Emiliangelo
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (05)
  • [3] A novel, orally available orexin 2 receptor-selective agonist with fast off-rate, TAK-994, induces wake-promoting effects in non-human primates
    Kimura, H.
    Ishikawa, T.
    Hara, H.
    Suzuki, M.
    JOURNAL OF SLEEP RESEARCH, 2020, 29 : 175 - 176
  • [4] AN OREXIN 2 RECEPTOR-SELECTIVE AGONIST TAK-925 AMELIORATES NARCOLEPSY-LIKE SYMPTOMS IN OREXIN/ATAXIN-3 MICE
    Suzuki, M.
    Yukitake, H.
    Ishikawa, T.
    Kimura, H.
    SLEEP, 2018, 41 : A1 - A1
  • [5] AN OREXIN 2 RECEPTOR-SELECTIVE AGONIST, TAK-925, AMELIORATES NARCOLEPSY-LIKE SYMPTOMS AND OBESITY IN OREXIN/ATAXIN-3 TRANSGENIC MICE
    Kimura, Haruhide
    Ishikawa, Takashi
    Yukitake, Hiroshi
    Suzuki, Motohisa
    SLEEP, 2019, 42
  • [6] TAK-925, AN OREXIN 2 RECEPTOR-SELECTIVE AGONIST, ENHANCED CORTICAL AROUSAL IN A NARCOLEPSY MOUSE MODEL DIFFERENT FROM EFFECTS OF MODAFINIL
    Kimura, H.
    Ishikawa, T.
    SLEEP, 2020, 43 : A56 - A56
  • [7] A NOVEL, ORALLY AVAILABLE OREXIN 2 RECEPTOR-SELECTIVE AGONIST, TAK-994, SHOWS WAKE-PROMOTING EFFECTS FOLLOWING CHRONIC DOSING IN AN OREXIN-DEFICIENT NARCOLEPSY MOUSE MODEL
    Ishikawa, T.
    Suzuki, M.
    Kimura, H.
    SLEEP, 2020, 43 : A56 - A56
  • [8] Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist
    Fujimoto, Tatsuhiko
    Rikimaru, Kentaro
    Fukuda, Koichiro
    Sugimoto, Hiromichi
    Masuda, Kei
    Ohyabu, Norio
    Banno, Yoshihiro
    Tokunaga, Norihito
    Kawamoto, Tetsuji
    Tomata, Yoshihide
    Kumagai, Yasumi
    Iida, Motoo
    Nagano, Yoichi
    Yoneyama-Hirozane, Mariko
    Shimizu, Yuji
    Sasa, Katsunori
    Ishikawa, Takashi
    Yukitake, Hiroshi
    Ito, Mitsuhiro
    Aoyama, Kazunobu
    Matsumoto, Takahiro
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (03): : 457 - 462
  • [9] TAK-925, an orexin 2 receptor-selective agonist, has a threshold plasma concentration to induce arousal in a narcolepsy mouse model.
    Kimura, H.
    Ishikawa, T.
    Hara, H.
    Aoyama, K.
    Yukitake, H.
    Suzuki, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1223 - 1223
  • [10] A SINGLE OVERNIGHT INFUSION OF TAK-925, A SELECTIVE OREXIN 2 RECEPTOR AGONIST, REDUCES OBSTRUCTIVE SLEEP APNEA SEVERITY
    Osman, A.
    Mukherjee, S.
    Loffler, K.
    Altree, T.
    Proctor, S.
    Adams, R.
    Nguyen, P.
    O'Reilly, C.
    Naik, G.
    Fauska, J.
    Yao, B.
    Toson, B.
    Cai, A.
    Buhl, D.
    Naylor, M.
    Olsson, T.
    Meyer, S.
    Rosen, L.
    Eckert, D.
    SLEEP MEDICINE, 2024, 115 : 326 - 326
12